 | DNM | Name: | N-methyl-D-norleucine | Formula: | C7 H15 N O2 | SMILES: | C(C(NC)CCCC)(=O)O | InChi: | InChI=1S/C7H15NO2/c1-3-4-5-6(8-2)7(9)10/h6,8H,3-5H2,1-2H3,(H,9,10)/t6-/m1/s1 | Definition date: | 2003-11-17 | Last modified: | 2024-09-27 | Identifier: | N-methyl-D-norleucine |
|
 | DO2 | Name: | 5,5-dihydroxy-6-oxo-L-norleucine | Formula: | C6 H11 N O5 | SMILES: | O=CC(O)(O)CCC(N)C(=O)O | InChi: | InChI=1S/C6H11NO5/c7-4(5(9)10)1-2-6(11,12)3-8/h3-4,11-12H,1-2,7H2,(H,9,10)/t4-/m0/s1 | Definition date: | 2000-01-07 | Last modified: | 2024-09-27 | Identifier: | 5,5-dihydroxy-6-oxo-L-norleucine |
|
 | DTU | Name: | (2R,3S)-1,4-DIMERCAPTOBUTANE-2,3-DIOL | Formula: | C4 H10 O2 S2 | SMILES: | SCC(O)C(O)CS | InChi: | InChI=1S/C4H10O2S2/c5-3(1-7)4(6)2-8/h3-8H,1-2H2/t3-,4+ | Definition date: | 2004-06-18 | Last modified: | 2024-09-27 | Identifier: | (2R,3S)-1,4-disulfanylbutane-2,3-diol |
|
 | DTV | Name: | (2S,3S)-1,4-DIMERCAPTOBUTANE-2,3-DIOL | Formula: | C4 H10 O2 S2 | SMILES: | SCC(O)C(O)CS | InChi: | InChI=1S/C4H10O2S2/c5-3(1-7)4(6)2-8/h3-8H,1-2H2/t3-,4-/m1/s1 | Definition date: | 2004-06-18 | Last modified: | 2024-09-27 | Identifier: | (2S,3S)-1,4-disulfanylbutane-2,3-diol |
|
 | DWZ | Name: | (2S,3R,4S)-4-{[(3S,5S)-5-(dimethylcarbamoyl)pyrrolidin-3-yl]sulfanyl}-2-[(2S,3R)-3-hydroxy-1-oxobutan-2-yl]-3-methyl-3,4-dihydro-2H-pyrrole-5-carboxylic acid | Formula: | C17 H27 N3 O5 S | SMILES: | CN(C)C(=O)C1CC(SC2C(C)C(N=C2C(=O)O)C(C=O)C(C)O)CN1 | InChi: | InChI=1S/C17H27N3O5S/c1-8-13(11(7-21)9(2)22)19-14(17(24)25)15(8)26-10-5-12(18-6-10)16(23)20(3)4/h7-13,15,18,22H,5-6H2,1-4H3,(H,24,25)/t8-,9-,10+,11-,12+,13-,15+/m1/s1 | Synonyms: | Meropenem, bound form | Definition date: | 2008-07-25 | Last modified: | 2024-09-27 | Identifier: | (2S,3R,4S)-4-{[(3S,5S)-5-(dimethylcarbamoyl)pyrrolidin-3-yl]sulfanyl}-2-[(2S,3R)-3-hydroxy-1-oxobutan-2-yl]-3-methyl-3,4-dihydro-2H-pyrrole-5-carboxylic acid |
|
 | DYA | Name: | DIDEHYDROASPARTATE | Formula: | C4 H5 N O4 | SMILES: | NC(=CC(O)=O)C(O)=O | InChi: | InChI=1S/C4H5NO4/c5-2(4(8)9)1-3(6)7/h1H,5H2,(H,6,7)(H,8,9)/b2-1- | Definition date: | 2015-04-24 | Last modified: | 2024-09-27 | Release date: | 2016-04-13 | Identifier: | (Z)-2-azanylbut-2-enedioic acid |
|
 | 6FL | Name: | 5,5,5,5',5',5'-hexafluoro-L-leucine | Formula: | C6 H7 F6 N O2 | SMILES: | FC(F)(F)C(CC(N)C(=O)O)C(F)(F)F | InChi: | InChI=1S/C6H7F6NO2/c7-5(8,9)3(6(10,11)12)1-2(13)4(14)15/h2-3H,1,13H2,(H,14,15)/t2-/m0/s1 | Definition date: | 2011-10-13 | Last modified: | 2024-09-27 | Identifier: | 5,5,5,5',5',5'-hexafluoro-L-leucine |
|
 | LVN | Name: | (3S)-4-oxo-L-valine | Formula: | C5 H9 N O3 | SMILES: | C[CH](C=O)[CH](N)C(O)=O | InChi: | InChI=1S/C5H9NO3/c1-3(2-7)4(6)5(8)9/h2-4H,6H2,1H3,(H,8,9)/t3-,4+/m1/s1 | Synonyms: | (2S,3S)-2-amino-3-methyl-4-oxo-butanoic acid | Definition date: | 2009-11-29 | Last modified: | 2024-09-27 | Identifier: | (2S,3S)-2-azanyl-3-methyl-4-oxo-butanoic acid |
|
 | LYF | Name: | (2E,4S)-2-{[(5S)-5-amino-5-carboxypentyl]imino}-4-hydroxyheptanedioic acid | Formula: | C13 H22 N2 O7 | SMILES: | O=C(O)C(N)CCCC/N=C(/C(=O)O)CC(O)CCC(=O)O | InChi: | InChI=1S/C13H22N2O7/c14-9(12(19)20)3-1-2-6-15-10(13(21)22)7-8(16)4-5-11(17)18/h8-9,16H,1-7,14H2,(H,17,18)(H,19,20)(H,21,22)/b15-10+/t8-,9-/m0/s1 | Definition date: | 2011-10-25 | Last modified: | 2024-09-27 | Identifier: | (2E,4S)-2-{[(5S)-5-amino-5-carboxypentyl]imino}-4-hydroxyheptanedioic acid |
|
 | LYH | Name: | 3,4 ENE-LYSINE | Formula: | C6 H12 N2 O2 | SMILES: | O=C(O)C(/C=C/CCN)N | InChi: | InChI=1S/C6H12N2O2/c7-4-2-1-3-5(8)6(9)10/h1,3,5H,2,4,7-8H2,(H,9,10)/b3-1+/t5-/m0/s1 | Synonyms: | (2S,3E)-2,6-DIAMINOHEX-3-ENOIC ACID | Definition date: | 2011-03-14 | Last modified: | 2024-09-27 | Release date: | 2012-08-24 | Identifier: | (2S,3E)-2,6-diaminohex-3-enoic acid |
|
 | LYJ | Name: | (2S)-2,6-diaminohexan-1-ol | Formula: | C6 H16 N2 O | SMILES: | OCC(N)CCCCN | InChi: | InChI=1S/C6H16N2O/c7-4-2-1-3-6(8)5-9/h6,9H,1-5,7-8H2/t6-/m0/s1 | Definition date: | 2012-01-18 | Last modified: | 2024-09-27 | Identifier: | (2S)-2,6-diaminohexan-1-ol |
|
 | LYK | Name: | (2S)-2,6-diaminohexane-1,1-diol | Formula: | C6 H16 N2 O2 | SMILES: | OC(O)C(N)CCCCN | InChi: | InChI=1S/C6H16N2O2/c7-4-2-1-3-5(8)6(9)10/h5-6,9-10H,1-4,7-8H2/t5-/m0/s1 | Definition date: | 2010-10-08 | Last modified: | 2024-09-27 | Identifier: | (2S)-2,6-diaminohexane-1,1-diol |
|
 | M2L | Name: | (2R)-2-amino-3-(2-dimethylaminoethylsulfanyl)propanoic acid | Formula: | C7 H16 N2 O2 S | SMILES: | O=C(O)C(N)CSCCN(C)C | InChi: | InChI=1S/C7H16N2O2S/c1-9(2)3-4-12-5-6(8)7(10)11/h6H,3-5,8H2,1-2H3,(H,10,11)/t6-/m0/s1 | Definition date: | 2008-04-09 | Last modified: | 2024-09-27 | Identifier: | S-[2-(dimethylamino)ethyl]-L-cysteine |
|
 | NFF | Name: | (2R,4S)-2-[(1R)-1-{[(2-ethoxynaphthalen-1-yl)carbonyl]amino}-2-oxoethyl]-5,5-dimethyl-1,3-thiazolidine-4-carboxylic
acid | Formula: | C21 H24 N2 O5 S | SMILES: | O=C(NC(C=O)C1SC(C(N1)C(=O)O)(C)C)c3c2ccccc2ccc3OCC | InChi: | InChI=1S/C21H24N2O5S/c1-4-28-15-10-9-12-7-5-6-8-13(12)16(15)18(25)22-14(11-24)19-23-17(20(26)27)21(2,3)29-19/h5-11,14,17,19,23H,4H2,1-3H3,(H,22,25)(H,26,27)/t14-,17+,19-/m1/s1 | Synonyms: | Nafcillin, bound form | Definition date: | 2010-06-28 | Last modified: | 2024-09-27 | Identifier: | (2R,4S)-2-[(1R)-1-{[(2-ethoxynaphthalen-1-yl)carbonyl]amino}-2-oxoethyl]-5,5-dimethyl-1,3-thiazolidine-4-carboxylic acid |
|
 | NOT | Name: | 6-azido-L-norleucine | Formula: | C6 H12 N4 O2 | SMILES: | [N-]=[N+]=N/CCCCC(N)C(=O)O | InChi: | InChI=1S/C6H12N4O2/c7-5(6(11)12)3-1-2-4-9-10-8/h5H,1-4,7H2,(H,11,12)/t5-/m0/s1 | Synonyms: | AZIDONORLEUCINE | Definition date: | 2009-05-08 | Last modified: | 2024-09-27 | Identifier: | 6-azido-L-norleucine |
|
 | NQG | Name: | 5-AZANYLIDYNE-N-[(2S)-4-ETHOXY-2-HYDROXY-4-OXOBUTANOYL]-L-NORVALYL-L-ARGINYL-L-TRYPTOPHANAMIDE | Formula: | C28 H39 N9 O7 | SMILES: | O=C(OCC)CC(O)C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N)Cc2c1ccccc1nc2)CCCNC(=[N@H])N)CCC#N | InChi: | InChI=1S/C28H39N9O7/c1-2-44-23(39)14-22(38)27(43)36-19(9-5-11-29)25(41)35-20(10-6-12-33-28(31)32)26(42)37-21(24(30)40)13-16-15-34-18-8-4-3-7-17(16)18/h3-4,7-8,15,19-22,34,38H,2,5-6,9-10,12-14H2,1H3,(H2,30,40)(H,35,41)(H,36,43)(H,37,42)(H4,31,32,33)/t19-,20-,21-,22-/m0/s1 | Definition date: | 2006-11-09 | Last modified: | 2024-09-27 | Identifier: | 5-azanylidyne-N-[(2S)-4-ethoxy-2-hydroxy-4-oxobutanoyl]-L-norvalyl-L-arginyl-L-tryptophanamide |
|
 | ML3 | Name: | 2-{[(2R)-2-amino-2-carboxyethyl]sulfanyl}-N,N,N-trimethylethanaminium | Formula: | C8 H19 N2 O2 S | SMILES: | O=C(O)C(N)CSCC[N+](C)(C)C | InChi: | InChI=1S/C8H18N2O2S/c1-10(2,3)4-5-13-6-7(9)8(11)12/h7H,4-6,9H2,1-3H3/p+1/t7-/m0/s1 | Definition date: | 2008-02-19 | Last modified: | 2024-09-27 | Identifier: | 2-{[(2R)-2-amino-2-carboxyethyl]sulfanyl}-N,N,N-trimethylethanaminium |
|
 | MP8 | Name: | (4R)-4-methyl-L-proline | Formula: | C6 H11 N O2 | SMILES: | O=C(O)C1NCC(C)C1 | InChi: | InChI=1S/C6H11NO2/c1-4-2-5(6(8)9)7-3-4/h4-5,7H,2-3H2,1H3,(H,8,9)/t4-,5+/m1/s1 | Definition date: | 2009-08-18 | Last modified: | 2024-09-27 | Identifier: | (4R)-4-methyl-L-proline |
|
 | MVA | Name: | N-METHYLVALINE | Formula: | C6 H13 N O2 | SMILES: | O=C(O)C(NC)C(C)C | InChi: | InChI=1S/C6H13NO2/c1-4(2)5(7-3)6(8)9/h4-5,7H,1-3H3,(H,8,9)/t5-/m0/s1 | Definition date: | 1999-07-08 | Last modified: | 2024-09-27 | Identifier: | N-methyl-L-valine |
|
 | MYK | Name: | N~6~-tetradecanoyl-L-lysine | Formula: | C20 H40 N2 O3 | SMILES: | O=C(O)C(N)CCCCNC(=O)CCCCCCCCCCCCC | InChi: | InChI=1S/C20H40N2O3/c1-2-3-4-5-6-7-8-9-10-11-12-16-19(23)22-17-14-13-15-18(21)20(24)25/h18H,2-17,21H2,1H3,(H,22,23)(H,24,25)/t18-/m0/s1 | Synonyms: | N6-myristoyl lysine | Definition date: | 2011-10-17 | Last modified: | 2024-09-27 | Identifier: | N~6~-tetradecanoyl-L-lysine |
|
 | 8BB | Name: | trans-4-{[(E)-1-amino-2-sulfanylethenyl]carbamoyl}cyclohexanecarboxylic acid | Formula: | C10 H16 N2 O3 S | SMILES: | O=C(O)C1CCC(C(=O)NC(=CS)N)CC1 | InChi: | InChI=1S/C10H16N2O3S/c11-8(5-16)12-9(13)6-1-3-7(4-2-6)10(14)15/h5-7,16H,1-4,11H2,(H,12,13)(H,14,15)/b8-5+/t6-,7- | Definition date: | 2012-01-04 | Last modified: | 2024-09-27 | Identifier: | trans-4-{[(E)-1-amino-2-sulfanylethenyl]carbamoyl}cyclohexanecarboxylic acid |
|
 | OBS | Name: | (Z)-N^6-[(4S,5R)-5-(2-CARBOXYETHYL)-4-(CARBOXYMETHYL)-1-HYDROXYDIHYDRO-2H-THIOPYRANIUM-3(4H)-YLIDENE]-L-LYSINE | Formula: | C16 H26 N2 O7 S | SMILES: | O=S1C/C(=N/CCCCC(C(=O)O)N)C(C(CCC(=O)O)C1)CC(=O)O | InChi: | InChI=1S/C16H26N2O7S/c17-12(16(23)24)3-1-2-6-18-13-9-26(25)8-10(4-5-14(19)20)11(13)7-15(21)22/h10-12H,1-9,17H2,(H,19,20)(H,21,22)(H,23,24)/b18-13-/t10-,11-,12+,26+/m1/s1 | Synonyms: | 2-AMINO-6-[5-(2-CARBOXY-ETHYL)-4-CARBOXYMETHYL-1-OXO-TETRAHYDRO-1LAMBDA4-THIOPYRAN-3-YLIDENEAMINO]-HEXANOIC ACID | Definition date: | 2005-09-11 | Last modified: | 2024-09-27 | Identifier: | (E)-N~6~-[(1S,4R,5S)-5-(2-carboxyethyl)-4-(carboxymethyl)-1-oxidodihydro-2H-thiopyran-3(4H)-ylidene]-L-lysine |
|
 | OEM | Name: | N-methyl-D-aspartic acid | Formula: | C5 H9 N O4 | SMILES: | O=C(O)C(NC)CC(=O)O | InChi: | InChI=1S/C5H9NO4/c1-6-3(5(9)10)2-4(7)8/h3,6H,2H2,1H3,(H,7,8)(H,9,10)/t3-/m1/s1 | Definition date: | 2010-08-17 | Last modified: | 2024-09-27 | Identifier: | N-methyl-D-aspartic acid |
|
 | OIB | Name: | hydroxylated gamma-amino valeroyl moiety | Formula: | C6 H13 N O5 | SMILES: | CO[CH](CN)[CH](O)[CH](O)C(O)=O | InChi: | InChI=1S/C6H13NO5/c1-12-3(2-7)4(8)5(9)6(10)11/h3-5,8-9H,2,7H2,1H3,(H,10,11)/t3-,4-,5-/m0/s1 | Synonyms: | (2~{S},3~{R},4~{S})-5-azanyl-4-methoxy-2,3-bis(oxidanyl)pentanoic acid | Definition date: | 2022-09-08 | Last modified: | 2024-09-27 | Release date: | 2023-08-16 | Identifier: | (2~{S},3~{R},4~{S})-5-azanyl-4-methoxy-2,3-bis(oxidanyl)pentanoic acid |
|
 | OIL | Name: | (2S,3S)-2-hydroxy-3-methylpentanoic acid | Formula: | C6 H12 O3 | SMILES: | O=C(O)C(O)C(C)CC | InChi: | InChI=1S/C6H12O3/c1-3-4(2)5(7)6(8)9/h4-5,7H,3H2,1-2H3,(H,8,9)/t4-,5-/m0/s1 | Definition date: | 2011-01-13 | Last modified: | 2024-09-27 | Identifier: | (2S,3S)-2-hydroxy-3-methylpentanoic acid |
|